Arrhythmia Disorders News

Boston Scientific announced it received FDA approval for its navigation-enabled ablation catheter for the treatment of paroxysmal atrial fibrillation and 510(k) clearance for new imaging software for its pulsed field ablation system.

The National Kidney Foundation Innovation Fund has invested in health technology company Revalia Bio, according to a press release.

Atrial fibrillation is a complex disease with ever-increasing treatment options, such as ablation, and advanced electrophysiology fellowship training is key to improving long-term outcomes, according to a new consensus statement.

Increased alcohol intake was associated with a significant increase in heart rate and an excess of atrial tachycardias in young adults with no history of cardiac arrhythmias, according to a study published in the European Heart Journal.

In this Healio video exclusive, Sana M. Al-Khatib, MD, professor of medicine at Duke University School of Medicine, discusses barriers to developing cardiovascular digital health solutions for women.

A meta-analysis of patients who underwent chimeric antigen receptor T-cell therapy for advanced blood cancers showed low prevalence of cardiovascular adverse events.

The American Heart Association Scientific Sessions will be held in-person only in Chicago from Nov. 16 to 18 and will feature eight late-breaking science sessions during the 3-day meeting.

A multidisciplinary quality improvement program to prevent cardiac arrest in the pediatric ICU provided sustained improvement in participating centers out to 2 years, researchers reported.

Health care has experienced a wave of technological advancements — such as AI, machine learning and wearables — in recent years, but if unchecked, they may exacerbate existing disparities in treatment and care.

Few areas in medicine have been impacted by AI as much as cardiac electrophysiology. While still in early stages, it is already influencing how electrophysiologists detect disease and predict outcomes.